Wadhwa M, Dilger P, Meager A, Walker B, Gaines-Das R, Thorpe R
Division of Immunobiology, National Institute for Biological Standards and Control, Herts, UK.
Cytokine. 1996 Dec;8(12):900-9. doi: 10.1006/cyto.1996.0121.
In this study, the authors examined the effects of recombinant human interleukin 4 (rhIL-4) and recombinant human tumour necrosis factor alpha (rhTNF-alpha) alone or in combination on proliferation of the human cytokine dependent myeloid cell line, M-O7e. While rhIL-4 or rhTNF-alpha alone induced only a weak proliferative response, a synergistic proliferative signal was clearly evident on stimulation of cells with a combination of both cytokines. The stimulatory effect of rhTNF-alpha is mediated predominantly by the 55-kDa TNF receptor because the agonistic monoclonal antibody htr-9 and the Trp32 Thr86 TNF-alpha mutant protein specific for this receptor type produced similar results to rhTNF-alpha. In contrast, the Asn143 Arg145 TNF-alpha mutant protein specific for the 75-kDa TNF receptor produced only minimal proliferation of M-O7e cells. Using RT-PCR, we found that rhTNF-alpha rapidly and strongly induced granulocyte-macrophage colony-stimulating factor (GM-CSF) mRNA production, while rhIL-4 was a slow and less efficient inducer of GM-CSF mRNA. However, there was little evidence of the TNF-alpha/IL-4 combination acting synergistically on GM-CSF mRNA production as the levels of GM-CSF mRNA increased only marginally compared with IL-4 or TNF-alpha alone. Thus, the observed synergistic effect of TNF-alpha/IL-4 costimulation of M-O7e cells seems to be mediated via induction of GM-CSF secretion rather than an enhanced production of GM-CSF mRNA. Higher levels of GM-CSF were detectable in supernatants of cells treated with both rhIL-4 and rhTNF-alpha than in cells stimulated with either cytokine alone. Furthermore, addition of a neutralising antibody against GM-CSF abrogated the observed synergistic effect of rhIL-4 and rhTNF-alpha treatment, indicating that the rhIL-4/TNF-alpha combination acts to significantly increase GM-CSF release which then acts in an autocrine manner to enhance the proliferation of M-O7e cells.
在本研究中,作者检测了重组人白细胞介素4(rhIL-4)和重组人肿瘤坏死因子α(rhTNF-α)单独或联合使用对人细胞因子依赖性髓系细胞系M-O7e增殖的影响。虽然单独使用rhIL-4或rhTNF-α仅诱导出微弱的增殖反应,但两种细胞因子联合刺激细胞时,明显出现了协同增殖信号。rhTNF-α的刺激作用主要由55 kDa的TNF受体介导,因为针对该受体类型的激动性单克隆抗体htr-9和Trp32 Thr86 TNF-α突变蛋白产生了与rhTNF-α相似的结果。相比之下,针对75 kDa TNF受体的Asn143 Arg145 TNF-α突变蛋白仅使M-O7e细胞产生极少的增殖。使用逆转录聚合酶链反应(RT-PCR),我们发现rhTNF-α能快速且强烈地诱导粒细胞巨噬细胞集落刺激因子(GM-CSF)mRNA的产生,而rhIL-4诱导GM-CSF mRNA的速度较慢且效率较低。然而,几乎没有证据表明TNF-α/IL-4联合使用对GM-CSF mRNA的产生有协同作用,因为与单独使用IL-4或TNF-α相比,GM-CSF mRNA的水平仅略有增加。因此,观察到TNF-α/IL-4对M-O7e细胞的协同刺激作用似乎是通过诱导GM-CSF分泌介导的,而不是通过增强GM-CSF mRNA的产生。与单独用任何一种细胞因子刺激的细胞相比,用rhIL-4和rhTNF-α处理的细胞上清液中可检测到更高水平的GM-CSF。此外,添加抗GM-CSF中和抗体消除了观察到的rhIL-4和rhTNF-α处理的协同效应,表明rhIL-4/TNF-α组合可显著增加GM-CSF的释放,然后以自分泌方式作用于增强M-O7e细胞的增殖。